April 26, 2021
A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two-phase three clinical trials of a new drug. The University of Manchester and Salford Royal NHS Foundation Trust led studies on Bimekizumab, both published in the prestigious New England Journal […]
